Status and Progress of Research on Metabolomics of Cervical Cancer
Cervical cancer is one of the most common gynecological malignant tumors in China. Given their lack of obviously early symptoms, more than half of patients with cervical cancer are diagnosed in the middle and late stages of this malignancy, resulting in poor prognosis. Finding new therapeutic target...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | Chinese |
Published: |
Magazine House of Cancer Research on Prevention and Treatment
2025-07-01
|
Series: | Zhongliu Fangzhi Yanjiu |
Subjects: | |
Online Access: | http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.1169 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839617183375687680 |
---|---|
author | Shaojun CHEN Ling GAN Xinkang CHEN Lingling XIONG Die LONG Lulu CHEN Mengzhuan WEI Li HUA Haixin HUANG |
author_facet | Shaojun CHEN Ling GAN Xinkang CHEN Lingling XIONG Die LONG Lulu CHEN Mengzhuan WEI Li HUA Haixin HUANG |
author_sort | Shaojun CHEN |
collection | DOAJ |
description | Cervical cancer is one of the most common gynecological malignant tumors in China. Given their lack of obviously early symptoms, more than half of patients with cervical cancer are diagnosed in the middle and late stages of this malignancy, resulting in poor prognosis. Finding new therapeutic targets is the current research direction. Metabolomics, as a new omics technology, is expected to provide new targets for tumor precision diagnosis and treatment through the analysis of the changes and potential mechanisms of metabolites in tumor occurrence and development by chromatography, mass spectrometry, and other technologies. Herein, we review the research methods of metabolomics; metabolic characteristics of cervical cancer; and progress of the research on metabolomics in cervical cancer diagnosis, curative effect prediction, and prognosis evaluation to provide new ideas for the precise diagnosis and treatment of cervical cancer. |
format | Article |
id | doaj-art-99b84d7cd58342dba3b876b1ad46a5f5 |
institution | Matheson Library |
issn | 1000-8578 |
language | zho |
publishDate | 2025-07-01 |
publisher | Magazine House of Cancer Research on Prevention and Treatment |
record_format | Article |
series | Zhongliu Fangzhi Yanjiu |
spelling | doaj-art-99b84d7cd58342dba3b876b1ad46a5f52025-07-25T01:40:43ZzhoMagazine House of Cancer Research on Prevention and TreatmentZhongliu Fangzhi Yanjiu1000-85782025-07-0152763063610.3971/j.issn.1000-8578.2025.24.116920241169Status and Progress of Research on Metabolomics of Cervical CancerShaojun CHEN0Ling GAN1Xinkang CHEN2Lingling XIONG3Die LONG4Lulu CHEN5Mengzhuan WEI6Li HUA7Haixin HUANG8Cancer Center, The Fourth Affiliated Hospital of Guangxi Medical University/Liuzhou Workers' Hospital, Liuzhou 545005, ChinaCancer Center, The Fourth Affiliated Hospital of Guangxi Medical University/Liuzhou Workers' Hospital, Liuzhou 545005, ChinaCancer Center, The Fourth Affiliated Hospital of Guangxi Medical University/Liuzhou Workers' Hospital, Liuzhou 545005, ChinaCancer Center, The Fourth Affiliated Hospital of Guangxi Medical University/Liuzhou Workers' Hospital, Liuzhou 545005, ChinaCancer Center, The Fourth Affiliated Hospital of Guangxi Medical University/Liuzhou Workers' Hospital, Liuzhou 545005, ChinaCancer Center, The Fourth Affiliated Hospital of Guangxi Medical University/Liuzhou Workers' Hospital, Liuzhou 545005, ChinaCancer Center, The Fourth Affiliated Hospital of Guangxi Medical University/Liuzhou Workers' Hospital, Liuzhou 545005, ChinaCancer Center, The Fourth Affiliated Hospital of Guangxi Medical University/Liuzhou Workers' Hospital, Liuzhou 545005, ChinaCancer Center, The Fourth Affiliated Hospital of Guangxi Medical University/Liuzhou Workers' Hospital, Liuzhou 545005, ChinaCervical cancer is one of the most common gynecological malignant tumors in China. Given their lack of obviously early symptoms, more than half of patients with cervical cancer are diagnosed in the middle and late stages of this malignancy, resulting in poor prognosis. Finding new therapeutic targets is the current research direction. Metabolomics, as a new omics technology, is expected to provide new targets for tumor precision diagnosis and treatment through the analysis of the changes and potential mechanisms of metabolites in tumor occurrence and development by chromatography, mass spectrometry, and other technologies. Herein, we review the research methods of metabolomics; metabolic characteristics of cervical cancer; and progress of the research on metabolomics in cervical cancer diagnosis, curative effect prediction, and prognosis evaluation to provide new ideas for the precise diagnosis and treatment of cervical cancer.http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.1169cervical cancermetabolomicsdiagnosispredictionprognosis |
spellingShingle | Shaojun CHEN Ling GAN Xinkang CHEN Lingling XIONG Die LONG Lulu CHEN Mengzhuan WEI Li HUA Haixin HUANG Status and Progress of Research on Metabolomics of Cervical Cancer Zhongliu Fangzhi Yanjiu cervical cancer metabolomics diagnosis prediction prognosis |
title | Status and Progress of Research on Metabolomics of Cervical Cancer |
title_full | Status and Progress of Research on Metabolomics of Cervical Cancer |
title_fullStr | Status and Progress of Research on Metabolomics of Cervical Cancer |
title_full_unstemmed | Status and Progress of Research on Metabolomics of Cervical Cancer |
title_short | Status and Progress of Research on Metabolomics of Cervical Cancer |
title_sort | status and progress of research on metabolomics of cervical cancer |
topic | cervical cancer metabolomics diagnosis prediction prognosis |
url | http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.1169 |
work_keys_str_mv | AT shaojunchen statusandprogressofresearchonmetabolomicsofcervicalcancer AT linggan statusandprogressofresearchonmetabolomicsofcervicalcancer AT xinkangchen statusandprogressofresearchonmetabolomicsofcervicalcancer AT linglingxiong statusandprogressofresearchonmetabolomicsofcervicalcancer AT dielong statusandprogressofresearchonmetabolomicsofcervicalcancer AT luluchen statusandprogressofresearchonmetabolomicsofcervicalcancer AT mengzhuanwei statusandprogressofresearchonmetabolomicsofcervicalcancer AT lihua statusandprogressofresearchonmetabolomicsofcervicalcancer AT haixinhuang statusandprogressofresearchonmetabolomicsofcervicalcancer |